At a glance
- Originator Solvay
- Class Anti-ischaemics; Antiarrhythmics; Cyclohexanes; Small molecules
- Mechanism of Action Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias
Most Recent Events
- 24 Nov 1994 Discontinued-Preclinical for Arrhythmias in Germany (Unknown route)